34385PAA6

Standard Biotools Inc.

Could not find a ticker for this position, may be a filing error

A maker of scientific instruments used by biomedical researchers to study individual cells and proteins. Its three platforms—CyTOF mass cytometry, Hyperion spatial proteomics, and Biomark genomics—are sold to academic labs, translational centers, and biopharma companies. Founded in 1999 as Mycometrix and renamed Fluidigm in 2001 (a play on the "fluid" microchips it builds), the company became Standard BioTools in 2022, after its microfluidics "integrated fluidic circuits" were born from a Caltech lab that manipulates fluids on chips much like electronics handle electrons.

5.25% Convertible Senior Notes due 2024